At week 0, after removing hemolysis, drug/alcoholism, steatohepatitis, and other liver damage factors, 4.55% (2/44) of patients in Group A and 7.7% (3/39) in Group B had HBV-related liver function damage (one or more of ALT/GGT/TBIL abnormal, as shown in Table 2), and all returned to normal after treatment with liver-protective drugs within 24 weeks. This evidence concerns the gene GPT and alcohol dependence.